Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Statin use and risk of multiple myeloma: An analysis from the cancer research network.

Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC.

Int J Cancer. 2017 Aug 1;141(3):480-487. doi: 10.1002/ijc.30745. Epub 2017 May 15.

PMID:
28425616
2.

Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).

Birmann BM, Andreotti G, De Roos AJ, Camp NJ, Chiu BCH, Spinelli JJ, Becker N, Benhaim-Luzon V, Bhatti P, Boffetta P, Brennan P, Brown EE, Cocco P, Costas L, Cozen W, de Sanjosé S, Foretová L, Giles GG, Maynadié M, Moysich K, Nieters A, Staines A, Tricot G, Weisenburger D, Zhang Y, Baris D, Purdue MP.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):876-885. doi: 10.1158/1055-9965.EPI-16-0762-T. Epub 2017 Feb 21.

PMID:
28223430
3.

Reply to Comment on 'Statin use and all-cancer survival: prospective results from the Women's Health Initiative'.

Wang A, Aragaki AK, Tang JY, Kurian AW, Manson JE, Chlebowski RT, Simon M, Desai P, Wassertheil-Smoller S, Liu S, Kritchevsky S, Wakelee HA, Stefanick ML.

Br J Cancer. 2017 Jan;116(3):e2. doi: 10.1038/bjc.2016.396. Epub 2016 Dec 6. No abstract available.

PMID:
27923034
4.

Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.

Cho SF, Yang YH, Liu YC, Hsiao HH, Huang CT, Wu CH, Tsai YF, Wang HC, Liu TC.

PLoS One. 2015 Oct 1;10(10):e0139289. doi: 10.1371/journal.pone.0139289. eCollection 2015.

5.

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.

Pradelli D, Soranna D, Zambon A, Catapano A, Mancia G, La Vecchia C, Corrao G.

Cancer Med. 2015 May;4(5):770-80. doi: 10.1002/cam4.411. Epub 2015 Mar 21.

6.

Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.

Yi X, Jia W, Jin Y, Zhen S.

PLoS One. 2014 Jan 31;9(1):e87019. doi: 10.1371/journal.pone.0087019. eCollection 2014.

7.

Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials.

Bonovas S, Nikolopoulos GK, Bagos PG.

PLoS One. 2012;7(9):e45259. doi: 10.1371/journal.pone.0045259. Epub 2012 Sep 19. Review.

8.

Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update.

Bassig BA, Lan Q, Rothman N, Zhang Y, Zheng T.

J Cancer Epidemiol. 2012;2012:978930. Epub 2012 Sep 12.

9.

Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.

Morimoto Y, Conroy SM, Ollberding NJ, Henning SM, Franke AA, Wilkens LR, Goodman MT, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Maskarinec G.

Cancer Causes Control. 2012 Oct;23(10):1693-703. doi: 10.1007/s10552-012-0048-1. Epub 2012 Aug 21.

10.

Continuation with statin therapy and the risk of primary cancer: a population-based study.

Lutski M, Shalev V, Porath A, Chodick G.

Prev Chronic Dis. 2012;9:E137. doi: 10.5888/pcd9.120005.

11.

HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons.

Chao C, Xu L, Abrams DI, Towner WJ, Horberg MA, Leyden WA, Silverberg MJ.

AIDS. 2011 Sep 10;25(14):1771-7. doi: 10.1097/QAD.0b013e328349c67a.

12.

Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.

Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, Paynter RA, Skibola DR, Agana L, Becker N, Tressler P, Forrest MS, Sankararaman S, Conde L, Holly EA, Smith MT.

PLoS One. 2008 Jun 30;3(7):e2816. doi: 10.1371/journal.pone.0002816.

13.

Statins impair antitumor effects of rituximab by inducing conformational changes of CD20.

Winiarska M, Bil J, Wilczek E, Wilczynski GM, Lekka M, Engelberts PJ, Mackus WJ, Gorska E, Bojarski L, Stoklosa T, Nowis D, Kurzaj Z, Makowski M, Glodkowska E, Issat T, Mrowka P, Lasek W, Dabrowska-Iwanicka A, Basak GW, Wasik M, Warzocha K, Sinski M, Gaciong Z, Jakobisiak M, Parren PW, Golab J.

PLoS Med. 2008 Mar 25;5(3):e64. doi: 10.1371/journal.pmed.0050064.

14.

Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.

Bonovas S, Filioussi K, Tsantes A, Sitaras NM.

Br J Clin Pharmacol. 2007 Sep;64(3):255-62. Epub 2007 Jun 19. Review.

Supplemental Content

Support Center